Cargando…
EGFR野生型晚期非小细胞肺癌的治疗进展
Lung cancer is the leading cause of death from cancer in the world. The treatment remains one of the most challenging tasks in the medical world. The discovery and development of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) have had a major impact in the treatment of non sma...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000467/ https://www.ncbi.nlm.nih.gov/pubmed/25034590 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.07.14 |